FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a pharmaceutical composition for preventing or treating inflammatory rheumatic diseases, including a histone deacetylase inhibitor and methotrexate as an effective component; to a method for treatment using the composition and to an application of the composition for producing a medicinal product for treating inflammatory rheumatic diseases, wherein the pharmaceutical composition in accordance with the invention displays an excellent effect of prevention or treatment of inflammatory rheumatic diseases.
EFFECT: creation of a pharmaceutical composition for use in the treatment of inflammatory rheumatic diseases.
6 cl, 10 ex, 22 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR TREATING DISEASE | 2009 |
|
RU2531548C2 |
MEDICAL PRODUCT AND METHOD OF RHEUMATIC DISEASES TREATMENT | 2006 |
|
RU2330664C2 |
USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2468806C2 |
METHOD FOR USING COMBINATION OF BENZOPHENOL DERIVATIVE AND SALT THEREOF, AND IMMUNOSUPPRESSIVE AGENTS, AND PHARMACEUTICAL COMPOSITION CONTAINING ABOVE INGREDIENTS | 2009 |
|
RU2496490C2 |
USE OF ARSENIC COMPOUNDS FOR PAIN MANAGEMENT AND INFLAMMATION TREATMENT | 2008 |
|
RU2630574C2 |
USE OF ARSENIC COMPOUNDS TO TREAT TISSUE OR ORGAN REJECTION | 2013 |
|
RU2665362C2 |
METHODS FOR TREATING METHOTREXATE-RESISTANT DISORDERS WITH 10-PROPARGYL-10-DEAZAAMINOPTERIN | 2011 |
|
RU2586299C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS, CONTAINING REBAMIPIDE | 2009 |
|
RU2496497C1 |
APPLICATION OF BENZOPHENOL DERIVATIVE OR ITS SALT AND TNF-α INHIBITOR IN COMBINATION, AND PHARMACEUTICAL COMPOSITION, CONTAINING THEREOF OR ITS SALT AND INHIBITOR | 2009 |
|
RU2522272C2 |
PROTEIN-BINDING METHOTREXATE DERIVATIVES AND MEDICINES CONTAINING SAID DERIVATIVES | 2007 |
|
RU2439077C2 |
Authors
Dates
2022-05-16—Published
2019-10-11—Filed